SAB Biotherapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of SAB Biotherapeutics shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in SAB Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including SAB Biotherapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SAB Biotherapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $685k | 996k | 0.69 |
| 2023-09-30 | $616k | 977k | 0.63 |
| 2023-06-30 | $799k | 963k | 0.83 |
| 2023-03-31 | $309k | 702k | 0.44 |
| 2022-12-31 | $414k | 702k | 0.59 |
| 2022-06-30 | $1.0M | 722k | 1.45 |
| 2022-03-31 | $2.7M | 721k | 3.76 |